Insider · CIK 0001250313

Maddon Paul J

CIK 0001250313 Name as filed on the most recent filing

Filed as Maddon Paul J (54)

72 transaction lines · from 54 filings · filed 2005-02-14 to 2016-04-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

72 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2010-12-01 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 24,500, acquired Open Form 4 filing 0001447348-16-000060
2010-12-01 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 24,500, acquired Open Form 4 filing 0001441844-10-000083
2010-11-01 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 23,800, acquired Open Form 4 filing 0001441844-10-000081
2010-10-04 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 24,950, acquired Open Form 4 filing 0001441844-10-000075
2010-09-01 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 20,500, acquired Open Form 4 filing 0001441844-10-000068
2010-08-02 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 23,750, acquired Open Form 4 filing 0001441844-10-000066
2010-07-16 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 2 lines 24,950, acquired Open Form 4 filing 0001441844-10-000065
2010-06-01 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 24,950, acquired Open Form 4 filing 0001441844-10-000032
2010-05-20 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 2 lines 24,630, acquired Open Form 4 filing 0001441844-10-000030
2009-10-16 P, Open-market purchase Progenics Pharmaceuticals IncPGNX 90,243, acquired Open Form 4 filing 0001447348-09-000020
2007-10-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 352,380, disposed Open Form 4 filing 0001266375-07-000078
2007-10-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 264,312, disposed Open Form 4 filing 0001266375-07-000070
2007-09-17 S, Open-market sale Progenics Pharmaceuticals IncPGNX 280,728, disposed Open Form 4 filing 0001266375-07-000069
2007-09-04 S, Open-market sale Progenics Pharmaceuticals IncPGNX 285,180, disposed Open Form 4 filing 0001266375-07-000068
2007-08-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 277,860, disposed Open Form 4 filing 0001266375-07-000066
2007-08-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 254,784, disposed Open Form 4 filing 0001266375-07-000065
2007-07-16 S, Open-market sale Progenics Pharmaceuticals IncPGNX 257,472, disposed Open Form 4 filing 0001266375-07-000061
2007-07-02 S, Open-market sale Progenics Pharmaceuticals IncPGNX 260,112, disposed Open Form 4 filing 0001266375-07-000047
2007-06-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 261,012, disposed Open Form 4 filing 0001266375-07-000040
2007-05-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 262,800, disposed Open Form 4 filing 0001266375-07-000038
2007-05-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 307,356, disposed Open Form 4 filing 0001266375-07-000037
2007-04-16 S, Open-market sale Progenics Pharmaceuticals IncPGNX 321,588, disposed Open Form 4 filing 0001266375-07-000034
2007-04-02 S, Open-market sale Progenics Pharmaceuticals IncPGNX 286,152, disposed Open Form 4 filing 0001266375-07-000027
2007-03-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 275,424, disposed Open Form 4 filing 0001266375-07-000024
2007-03-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 317,832, disposed Open Form 4 filing 0001266375-07-000023
2007-02-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 358,716, disposed Open Form 4 filing 0001266375-07-000019
2007-02-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 358,632, disposed Open Form 4 filing 0001266375-07-000016
2007-01-16 S, Open-market sale Progenics Pharmaceuticals IncPGNX 342,912, disposed Open Form 4 filing 0001266375-07-000012
2007-01-03 S, Open-market sale Progenics Pharmaceuticals IncPGNX 308,124, disposed Open Form 4 filing 0001266375-07-000007
2006-12-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 313,668, disposed Open Form 4 filing 0001266375-06-000113
2006-12-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 2 lines 321,843, disposed Open Form 4 filing 0001266375-06-000109
2006-11-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 2 lines 349,752, disposed Open Form 4 filing 0001266375-06-000105
2006-11-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 311,568, disposed Open Form 4 filing 0001266375-06-000100
2006-10-16 S, Open-market sale Progenics Pharmaceuticals IncPGNX 288,000, disposed Open Form 4 filing 0001266375-06-000096
2006-10-02 S, Open-market sale Progenics Pharmaceuticals IncPGNX 280,476, disposed Open Form 4 filing 0001266375-06-000088
2006-09-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 4 lines 287,350, disposed Open Form 4 filing 0001266375-06-000087
2006-09-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 272,640, disposed Open Form 4 filing 0001266375-06-000085
2006-08-15 S, Open-market sale Progenics Pharmaceuticals IncPGNX 242,412, disposed Open Form 4 filing 0001266375-06-000084
2006-08-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 2 lines 258,900, disposed Open Form 4 filing 0001266375-06-000082
2006-07-17 S, Open-market sale Progenics Pharmaceuticals IncPGNX 253,224, disposed Open Form 4 filing 0001266375-06-000081
2006-07-03 S, Open-market sale Progenics Pharmaceuticals IncPGNX 2 lines 286,044, disposed Open Form 4 filing 0001266375-06-000073

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 12
  • Open-market sale 60
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. MADDON PAUL J, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001250313

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.